scholarly journals A comparative study of duplex guided Foam sclerotherapy and liquid sclerotherapy for the treatment of lower extremity varicose veins

2021 ◽  
Vol 09 (12) ◽  
Author(s):  
Dr Ankit Agarwal ◽  
Medicine ◽  
2020 ◽  
Vol 99 (22) ◽  
pp. e20332
Author(s):  
Minglei Bi ◽  
Danyi Li ◽  
Zhenyu Chen ◽  
Yanjin Wang ◽  
Jizhen Ren ◽  
...  

VASA ◽  
2017 ◽  
Vol 46 (6) ◽  
pp. 484-489 ◽  
Author(s):  
Tom Barker ◽  
Felicity Evison ◽  
Ruth Benson ◽  
Alok Tiwari

Abstract. Background: The invasive management of varicose veins has a known risk of post-operative deep venous thrombosis and subsequent pulmonary embolism. The aim of this study was to evaluate absolute and relative risk of venous thromboembolism (VTE) following commonly used varicose vein procedures. Patients and methods: A retrospective analysis of secondary data using Hospital Episode Statistics database was performed for all varicose vein procedures performed between 2003 and 2013 and all readmissions for VTE in the same patients within 30 days, 90 days, and one year. Comparison of the incidence of VTEs between procedures was performed using a Pearson’s Chi-squared test. Results: In total, 261,169 varicose vein procedures were performed during the period studied. There were 686 VTEs recorded at 30 days (0.26 % incidence), 884 at 90 days (0.34 % incidence), and 1,246 at one year (0.48 % incidence). The VTE incidence for different procedures was between 0.15–0.35 % at 30 days, 0.26–0.50 % at 90 days, and 0.46–0.58 % at one year. At 30 days there was a significantly lower incidence of VTEs for foam sclerotherapy compared to other procedures (p = 0.01). There was no difference in VTE incidence between procedures at 90 days (p = 0.13) or one year (p = 0.16). Conclusions: Patients undergoing varicose vein procedures have a small but appreciable increased risk of VTE compared to the general population, with the effect persisting at one year. Foam sclerotherapy had a lower incidence of VTE compared to other procedures at 30 days, but this effect did not persist at 90 days or at one year. There was no other significant difference in the incidence of VTE between open, endovenous, and foam sclerotherapy treatments.


2016 ◽  
pp. 68-74
Author(s):  
V.N. Antonuk-Kissel ◽  
◽  
V.N. Yenikeyeva ◽  
S.I. Lichner ◽  
V.M. Lipniy ◽  
...  

2013 ◽  
Vol 33 (1) ◽  
pp. 88-91
Author(s):  
Xiao-bing ZHENG ◽  
Qing-qing WANG ◽  
Ren-an CHANG ◽  
Zhi-xian HE

Author(s):  
Archit Kohli ◽  
Harsh Makad ◽  
Nihar Parekh ◽  
Shubhankar Pandey ◽  
Dattatray Sawant ◽  
...  

2017 ◽  
Vol 5 ◽  
pp. 2050313X1771264 ◽  
Author(s):  
Mark S Whiteley ◽  
Victoria C Smith

A 40-year-old woman with a history of alopecia areata related to stress or hormonal changes was treated for bilateral primary symptomatic varicose veins (CEAP clinical score C2S) of pelvic origin, using a staged procedure. Her first procedure entailed pelvic vein embolisation of three pelvic veins using 14 coils and including foam sclerotherapy of the tributaries, using 3% sodium tetradecyl sulphate. Following this procedure, she had an exacerbation of alopecia areata with some moderate shedding of hair. Subsequently, she underwent endovenous laser ablation under local anaesthetic without incident. Seven months after the pelvic vein embolisation, she underwent foam sclerotherapy of leg and labial varicose veins using sodium tetradecyl sulphate. Two days following this procedure, she had a severe exacerbation of alopecia areata with gross shedding of hair. These two episodes of exacerbation of alopecia areata appear to be associated with sodium tetradecyl sulphate foam sclerotherapy of veins.


Sign in / Sign up

Export Citation Format

Share Document